Administer alteplase (tPA) — Indicated
💎 The client has findings consistent with an acute ischemic stroke, including left-sided facial droop, left arm weakness, and left visual field deficit.
💎 The client was last known well at 0745 and is being evaluated at 0930, which is within the usual 4.5-hour thrombolytic treatment window.
💎 The CT scan shows no hemorrhage, which is essential before giving alteplase because tPA is contraindicated in hemorrhagic stroke.
💎 Coagulation labs are acceptable: PT 11.2 seconds, aPTT 30 seconds, INR 1.1, meaning there is no obvious clotting abnormality.
💎 Blood pressure is 180/99 mm Hg, which is below the usual tPA exclusion threshold of 185/110 mm Hg, so alteplase is appropriate if no other contraindications exist.
Consult social work regarding home care assistance at discharge — Nonessential
🔷 Social work may be helpful later because stroke clients often need rehabilitation planning, home safety evaluation, equipment support, and discharge resources.
🔷 However, this client is in the acute stroke phase, where the immediate priorities are brain perfusion, stroke treatment, neurological monitoring, and preventing complications.
🔷 Discharge planning is important, but it does not address the client’s urgent neurological deficits.
🔷 The client is still being evaluated for acute treatment, so home care planning is not the priority at this moment.
🔷 This order is appropriate later but nonessential right now.
Administer D5W intravenously — Contraindicated
🟢 D5W is hypotonic after dextrose is metabolized and can shift water into cells, which may worsen cerebral edema in a client with acute stroke.
🟢 Clients with acute brain injury are at risk for increased intracranial pressure, and hypotonic fluids can increase swelling in brain tissue.
🟢 The client’s glucose is 119 mg/dL, which is normal, so there is no hypoglycemia requiring dextrose administration.
🟢 Hyperglycemia can worsen neurological outcomes after stroke, so unnecessary dextrose-containing fluids should be avoided.
🟢 Isotonic fluids, such as 0.9% sodium chloride, are generally preferred when IV fluid support is needed in acute stroke.
Administer ibuprofen (Motrin) — Contraindicated
🟣 Ibuprofen is an NSAID that can increase the risk of bleeding, especially when thrombolytic therapy such as alteplase is being considered or administered.
🟣 In acute stroke care, medications that increase bleeding risk should be avoided unless specifically ordered after careful evaluation.
🟣 The client may receive alteplase, which already increases bleeding risk by breaking down clots.
🟣 Giving ibuprofen could increase the risk of intracranial hemorrhage or gastrointestinal bleeding.
🟣 The client only reports mild pain of 2/10, so ibuprofen is not appropriate as a priority intervention.
MRI of the brain without contrast — Indicated
🔶 MRI without contrast can provide more detailed information about ischemic brain injury than CT in some cases.
🔶 The initial CT ruled out mass, hemorrhage, and hydrocephalus, but early ischemic stroke changes may not always be visible immediately on CT.
🔶 MRI can help confirm the location and extent of infarction and guide ongoing stroke management.
🔶 A noncontrast MRI is appropriate because contrast is not always needed to evaluate acute ischemic changes.
🔶 This intervention supports diagnosis and treatment planning, especially when neurological deficits are present.